The role of interleukin 2 (IL-2) in the activation of suppressor T cells was investigated by using the monoclonal antibody anti-Tac, which blocks the binding of IL-2 to the 55-kDa peptide of the high-affinity IL-2 receptor.
Anti-Tac was added to an antigen-nonspecific suppressor system in which Con A-induced suppressor T cells were generated during a preculture period, and their effects on immunoglobulin production were assessed in second, indicator cultures containing pokeweed mitogen and peripheral blood mononuclear cells. Anti-Tac added during the preculture period inhibited Con A-induced suppressor T-cell generation. Cells activated by a short (2-day) preculture period to become effectors of suppression were primarily of the Tac-positive, T8 (CD8)-positive phenotype. Tac-positive, T8-negative T cells might also contribute to the suppressor activity. Our studies indicate that anti-Tac, by producing a functional blockade of human high-affinity IL-2 receptors, inhibits the generation of antigen-nonspecific suppressor T cells.
Human T cells become activated after the interaction of specific receptors with antigen presented in the context of products of the major histocompatibility locus and macrophage-derived interleukin 1 (IL-1) or IL-6. As a consequence of this interaction, T cells produce the growth factor IL-2 (1-3). To exert its biological effect, IL-2 must interact with specific high-affinity membrane receptors on target T cells (3) (4) (5) . The high-affinity IL-2 receptor is a multichain complex containing at least two IL-2-binding peptides with apparent molecular masses of55 kDa (p55) and 68-76 kDa (p75) (6) (7) (8) (9) (10) . Anti-Tac, a monoclonal antibody that binds to the 55-kDa peptide of the human IL-2 receptor, blocks the interaction of IL-2 with this receptor peptide and acts as an antagonist for those reactions requiring this interaction (6) (7) (8) .
In previous reports, anti-Tac was shown to inhibit soluble antigen-, autoantigen-, and alloantigen-induced T-cell proliferation (11, 12) . In addition, anti-Tac inhibited T-cell proliferation induced by mitogenic lectins (12) . Anti-Tac abrogated the generation of cytotoxic T lymphocytes in allogeneic cell cultures but did not inhibit their action once generated (11) . Anti-Tac inhibited the sequential development of lateappearing activation antigens on T cells (13, 14) . Furthermore, anti-Tac inhibited the production of immunoglobulins by B cells stimulated by polyclonal activators (15, 16 (17) (18) (19) .
The activation and mode of action of suppressor T cells differ in a number of ways from those of helper and cytotoxic T cells. For example, antigen-specific suppressor cells do not appear to use the P chain in their receptor and thus may express an antigen receptor other than the a/0 heterodimer (20, 21) . In this paper, we report on the functional effects of anti-Tac on the in vitro generation of suppressor T lymphocytes induced by Con A. We demonstrate that anti-Tac inhibits Con A-induced suppressor T-cell generation.
MATERIALS AND METHODS
Antibodies. The preparation of anti-Tac has been described (6) . A murine myeloma protein (RPC-5; Litton Bionetics, Rockville, MD) of the same isotype (IgG2a) but nonreactive with human cells was used as a control for the anti-Tac monoclonal antibody. The OKT4 and OKT8 antibodies were obtained from Ortho Diagnostics.
Separation of Cells. Peripheral blood mononuclear cells (PMBCs) were separated from heparinized blood of normal volunteers by Ficoll-Paque (Pharmacia) density gradient centrifugation. T cells were isolated by rosette formation with neuraminidase-treated sheep erythrocytes. To obtain subpopulations of T cells, isolated T-cell populations were treated, after the preincubation step used to generate suppressor cells, either with OKT4 (1:100 dilution), OKT8 (1: 100), anti-Tac (20 ,ug/ml), or RPC-5 (20 ,ug/ml) for 30 min at room temperature, followed by addition of rabbit (3-to 4 weeks old) complement (Pel-Freez Biologicals, Rogers, AR), or with complement alone. Con A-stimulated T cells were separated into Tac-positive and Tac-negative populations by a rosette technique employing bovine erythrocytes coated with staphylococcal protein A (Pharmacia Fine Chemicals), as described (11) . The purity of the T-cell populations described above was analyzed by direct immunofluorescence.
Stimulants. Con A (Sigma) at 10 pug/ml and pokeweed mitogen (PWM; GIBCO) at a dilution of 1 
RESULTS
Blockade of the IL-2 Receptor by Anti-Tac Inhibits Con A-Induced Generation of Suppressor T Cells. We examined the ability of purified anti-Tac monoclonal antibody to inhibit the Con A-induced generation of suppressor T cells. Peripheral blood T cells were cultured for 48 hr with Con A (10 ,ug/ml), Con A and anti-Tac (20 ,ug/ml), Con A and RPC-5 (20 ,g/ml), or culture medium alone. To assess suppressor T-cell activity at the termination of the culture, the cells were washed and then added to an indicator PBMC/PWM assay system. Seven days later, polyclonal immunoglobulin production by PBMCs was assayed by the reverse hemolytic plaque technique. The results of 10 experiments are summarized in Fig of an equal number of T cells precultured for 48 hr with Con A alone inhibited the generation of immunoglobulin-secreting cells by 65 + 5.8% (mean ± SEM). However, the suppressor activity of Con A-stimulated cells was decreased from 65% to 26% (P < 0.020 between this value and that with Con A alone) when anti-Tac was added during the preculture period. There was no decrease in suppressor activity of Con A-stimulated cells when the monoclonal antibody RPC-5 was added throughout the preculture period. Furthermore, addition of anti-Tac for only the last 15 min of the preculture period before the washing step did not diminish the suppressor activity, indicating that carryover of anti-Tac into the indicator system was not the cause of the diminished suppressor activity observed.
We determined whether the inhibition of the generation of suppressor cells by anti-Tac could be overcome by the addition of IL-2 to the cultures. T cells precultured with Con A alone inhibited plaque-forming cell colonies in the indicator system by 50% (Table 1) . However, the degree of suppression was reduced to 12% by the addition of anti-Tac (20 ,g/ml) to the culture system. This inhibition of suppression was completely reversed by the addition of IL-2 (125 ng/ml) to the precultures containing Con A and anti-Tac. Thus, anti-Tac inhibited the generation of Con A-induced suppressor T cells, whereas IL-2 in the initial culture significantly augmented the activity of these cells (P < 0.01; Exp. 4 compared with Exp. 1). This result suggested that anti-Tac inhibits by preventing the binding of IL-2 to its specific receptor on T cells. When IL-2 (10 or 50 ng/ml) was added to the second, indicator culture system with T cells precultured with Con A, the suppression was augmented, whereas no suppressor activity was observed when IL-2 was added to the second culture with T cells precultured with medium alone (data not shown). Hence, the adsorption of IL-2 by the T cells precultured with Con A was not the cause of the suppression observed in the second culture system. Tac Antigen on the Suppressor Effectors. To determine whether the effectors of suppression express the Tac antigen, a series of experiments was performed. After the primary culture of T cells with Con A, Tac-positive and Tac-negative cells were separated by a rosette method using protein None 673 x/. 1.33 T cells were precultured with Con A (10 jg/ml) for 2 days (Exp.
3). Tac-positive T cells (Exp. 1) and Tac-negative T cells (Exp. 2) were separated from the Con A-precultured T-cell population. These T cells, or T cells precultured without Con A (Exp. 4), were added to the second culture system. For the second culture the precultured cells were added to PBMCs with PWM ( Exps. 1-4) anti-Tac inhibits protein synthesis and viability of Tacexpressing T-cell lines (23) . The addition of Pseudomonas exotoxin-anti-Tac for the last 24 hr of a Con A preculture significantly reduced the suppressor activity relative to that of cells cultured for 72 hr with Con A alone (P < 0.005) or of cells cultured with Con A for 72 hr and then with either anti-Tac (P < 0.005) or RPC-5 (P < 0.020) for the last 24 hr of the preculture period. Furthermore, suppressor T cells induced by Con A in a 48-hr preculture did not lose their suppressor activity after exposure to anti-Tac in the next 24-hr culture.
The Phenotype of the Suppressor Effector Cels. Additional studies were performed to define the phenotype of the suppressor effector cells. As defined by flow cytometry using monoclonal antibodies, the T cells to be incubated with Con A were 31% T8 (CD8)-positive and 51% T4 (CD4)-positive at the initiation of culture. Less than 10%1 of the cells expressed the Tac antigen at the initiation of culture. T8 and T4 subpopulations were isolated at the initiation ofthe culture by treatment of the cells with OKT4 and OKT8 monoclonal antibodies, respectively, and complement. The efficacy of the elimination of cells with the appropriate phenotype was confirmed by flow cytometry. Forty-one percent of the T4 cells incubated with Con A for 48 hr expressed the Tac antigen, whereas 18% of the T8-positive cells expressed it after the preculture period. The depletion of T4-positive cells from lymphocytes that had been precultured with Con A did not reduce the suppressor capacity of the remaining cells (Table 4) . However, elimination of T8-positive cells by antibody and complement reduced but did not eliminate suppressor activity. In these studies, treatment with anti-Tac and complement completely eliminated suppressor effector function of the Con A-precultured T cells. Thus, suppressor activity in lymphocytes precultured with Con A is manifested by Tac-positive, T8-positive lymphocytes. Furthermore, Tac-positive, T8-negative cells may also contribute to it. blockade of the interaction of IL-2 with its cell-surface receptor. Previously, anti-Tac was shown to block T-cell proliferation induced by soluble antigens (80-90%o), autologous antigens (90%), or alloantigens (75-90%) (11, 12) . Furthermore, anti-Tac abrogated the generation of cytotoxic T lymphocytes in allogeneic cell cocultures (>95%) but did not inhibit killing by these cytotoxic lymphocytes once formed (11) . Anti-Tac did not, however, completely inhibit all T-cell functions in vitro. This may indicate that such functions involve the use ofa non-Tac IL-2-receptor peptide (e.g., p75) or use a lymphokine other than IL-2 (e.g., IL4). Although anti-Tac effectively inhibited the mitogenic response to suboptimal amounts of lectins such as phytohemagglutinin and PWM, it only partially inhibited optimal mitogenic lectin-induced proliferation (12) . Because IL-2 has a higher affinity for its high-affinity receptor (Kd = 10-11 M) than does anti-Tac (Kd = 10' M), the inability of anti-Tac to abrogate the response to optimal doses of mitogen may reflect response to the IL-2 elaborated. Furthermore, both Tac-negative and Tac-positive T-cell populations that had been precultured with PWM were shown to provide helper activity in a PWM-induced immunoglobulin-production system (11) . Finally, the addition of anti-Tac did not prevent certain Tac-negative cells (e.g., large granular lymphocytes that are precursors of activated natural killer cells or lymphokine-activated killer cells) from making a nonproliferative response to IL-2 (17, 18) . These latter responses appear to involve the interaction of IL-2 with the 75-kDa IL-2-binding peptide (9, 19) . Schneider et al. (24) and Kupiec-Weglinski et al. (25) reported that therapy with a monoclonal antibody to the IL-2 receptor prevents acute allograft rejection in rats. Those authors suggested that suppressor mechanisms are inhibited less than effector mechanisms by IL-2 receptortargeted therapy.
A previous study (12) indicated that anti-Tac produces a functional blockade of human high-affinity IL-2 receptors on T cells that express the Tac peptide and that this antibody thus provides a valuable tool to probe for the presence of highaffinity IL-2 receptors and events mediated by the interaction of IL-2 with such receptors. In the present study, we examined the effect ofthe blockade ofthe IL-2 receptor by anti-Tac antibody on the differentiation of suppressor T cells by utilizing a system in which suppressor T cells were generated during a preculture period and their effect was assessed in second, indicator cultures. Con A induces suppressor-effector T cells from inactive precursors. Once generated, such cells are antigennonspecific and genetically nonrestricted and act to inhibit both T-and B-cell functions. The anti-Tac incorporated into the preculture system inhibited the generation ofsuppressor T cells, suggesting that the interaction of IL-2 with its high-affinity receptor and the consequent T-cell proliferation are required for the generation of suppressor T-cells. Theoretically, anti-Tac could act on any or all of the interacting cells involved in the generation of suppressor effectors, including suppressorinducer cells as well as the precursors ofthe suppressor-effector cells. Cells activated by a short (2-day) preculture period to become effectors of suppression were primarily of the Tacpositive phenotype; that is, the suppressor activity could be depleted by treatment with anti-Tac antibody and complement. Furthermore, when Con A-stimulated T cells were separated into Tac-positive and Tac-negative cell populations by a rosetting technique using protein A-coated bovine erythrocytes, all suppressor activity was contained in the Tac-positive population. Thus, in the systems examined, the suppressor cells appeared to express the Tac antigen during a phase of their generation.
There are a number of differences between the studies of Schneider (24) and Kupiec-Weglinski (25) and their coworkers, which suggested that suppressor cells are spared by therapy with monoclonal antibodies to the IL-2 receptor, and the present study, wherein we conclude that IL-2 plays a pivotal role in the differentiation of suppressor T cells. In the previous studies, the monoclonal antibody was added in vivo following the allograft, and antigen-specific suppressors were examined. In contrast, in this in vitro study, the antibody was present throughout the preculture period when suppressor cells were generated, and these suppressor cells were antigen-nonspecific. In other studies, we have found that the addition of anti-Tac during the preculture period also inhibited the generation of antigen-specific suppressor T cells induced by high antigen (sheep erythrocytes) concentrations (T.O.-I., J.M., and T.A.W., unpublished observations).
The present study of the effect of anti-Tac on the generation of suppressor T cells and on suppressor T-cell effectors may be of significance to the use of this antibody to modulate human immune responses in vivo. Studies have been initiated utilizing unmodified anti-Tac as well as Pseudomonas exotoxin-conjugated anti-Tac in the therapy of patients with Tac-positive adult T-cell leukemia (26) . Anti-Tac is also being used in organ allograft studies (27) . Based on the results ofthe present study, it is conceivable that anti-Tac would inhibit the generation of suppressor T cells that normally participate in the development of immunological tolerance to the grafted organ. Furthermore, Zoumbos et al. (28) have demonstrated that Tac antigen-expressing, T8-positive T cells are increased in the circulation of patients with aplastic anemia, who are Proc. Nadl. Acad. Sci. USA 85 (1988) known to have increased suppressor lymphocyte activity, and that only Tac-positive cells manifested hematopoietic suppressor activity. These results suggested to those authors that Tac-positive activated suppressor lymphocytes have a role in the pathogenesis of the bone marrow failure in certain patients with aplastic anemia. These studies suggest that IL-2 receptor-directed therapy might be of value in patients with autoimmune disease whose Tac-expressing suppressor T cells play a role in the pathogenesis of their disease.
